Narayana Hrudayalaya Limited

NSEI:NH Stock Report

Market Cap: ₹275.4b

Narayana Hrudayalaya Valuation

Is NH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
₹728.49
Fair Value
86.2% overvalued intrinsic discount
13
Number of Analysts

Below Fair Value: NH (₹1356.1) is trading above our estimate of fair value (₹728.49)

Significantly Below Fair Value: NH is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NH?

Key metric: As NH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NH. This is calculated by dividing NH's market cap by their current earnings.
What is NH's PE Ratio?
PE Ratio35.4x
Earnings₹7.79b
Market Cap₹275.42b

Price to Earnings Ratio vs Peers

How does NH's PE Ratio compare to its peers?

The above table shows the PE ratio for NH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average69.2x
KIMS Krishna Institute of Medical Sciences
78.4x25.3%₹259.7b
MEDANTA Global Health
61x19.7%₹309.7b
FORTIS Fortis Healthcare
77.1x27.5%₹505.6b
RAINBOW Rainbow Children's Medicare
60.3x23.8%₹139.7b
NH Narayana Hrudayalaya
35.4x13.4%₹275.4b

Price-To-Earnings vs Peers: NH is good value based on its Price-To-Earnings Ratio (35.4x) compared to the peer average (69.2x).

Price to Earnings Ratio vs Industry

How does NH's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.2xn/aUS$12.70m
542918 Gian Life Care
4.4xn/aUS$1.97m
No more companies available in this PE range
NH 35.4xIndustry Avg. 42.4xNo. of Companies7PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: NH is good value based on its Price-To-Earnings Ratio (35.4x) compared to the Indian Healthcare industry average (42.4x).

Price to Earnings Ratio vs Fair Ratio

What is NH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio35.4x
Fair PE Ratio41.9x

Price-To-Earnings vs Fair Ratio: NH is good value based on its Price-To-Earnings Ratio (35.4x) compared to the estimated Fair Price-To-Earnings Ratio (41.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹1,356.10
₹1,389.54
+2.5%
13.3%₹1,650.00₹1,013.00n/a13
Jan ’26₹1,312.50
₹1,382.75
+5.4%
13.0%₹1,650.00₹1,030.00n/a12
Dec ’25₹1,266.70
₹1,373.17
+8.4%
12.4%₹1,650.00₹1,030.00n/a12
Nov ’25₹1,248.20
₹1,364.33
+9.3%
11.9%₹1,600.00₹1,030.00n/a12
Oct ’25₹1,236.90
₹1,369.08
+10.7%
11.4%₹1,600.00₹1,000.00n/a12
Sep ’25₹1,268.95
₹1,396.27
+10.0%
8.2%₹1,600.00₹1,146.00n/a11
Aug ’25₹1,252.75
₹1,379.40
+10.1%
8.2%₹1,558.00₹1,146.00n/a10
Jul ’25₹1,216.10
₹1,379.30
+13.4%
8.3%₹1,558.00₹1,145.00n/a10
Jun ’25₹1,189.25
₹1,366.90
+14.9%
8.2%₹1,558.00₹1,145.00n/a10
May ’25₹1,287.10
₹1,421.70
+10.5%
9.3%₹1,669.00₹1,145.00n/a10
Apr ’25₹1,296.30
₹1,427.67
+10.1%
9.6%₹1,669.00₹1,152.00n/a9
Mar ’25₹1,296.25
₹1,427.67
+10.1%
9.6%₹1,669.00₹1,152.00n/a9
Feb ’25₹1,363.25
₹1,286.33
-5.6%
8.8%₹1,540.00₹1,152.00₹1,352.209
Jan ’25₹1,203.40
₹1,252.11
+4.0%
7.1%₹1,410.00₹1,147.00₹1,312.509
Dec ’24₹1,225.30
₹1,219.50
-0.5%
9.0%₹1,410.00₹990.00₹1,266.7010
Nov ’24₹997.65
₹1,111.00
+11.4%
7.2%₹1,280.00₹990.00₹1,248.209
Oct ’24₹1,085.50
₹1,106.50
+1.9%
7.6%₹1,280.00₹990.00₹1,236.908
Sep ’24₹1,024.25
₹1,100.88
+7.5%
8.0%₹1,280.00₹990.00₹1,268.958
Aug ’24₹1,014.90
₹989.25
-2.5%
6.6%₹1,100.00₹885.00₹1,252.758
Jul ’24₹993.25
₹989.25
-0.4%
6.6%₹1,100.00₹885.00₹1,216.108
Jun ’24₹910.60
₹938.78
+3.1%
7.3%₹1,019.00₹789.00₹1,189.259
May ’24₹761.85
₹877.63
+15.2%
7.4%₹976.00₹789.00₹1,287.108
Apr ’24₹774.15
₹877.63
+13.4%
7.4%₹976.00₹789.00₹1,296.308
Mar ’24₹742.90
₹872.86
+17.5%
7.9%₹976.00₹789.00₹1,296.257
Feb ’24₹712.15
₹816.86
+14.7%
8.1%₹920.00₹708.00₹1,363.257
Analyst Price Target
Consensus Narrative from 13 Analysts
₹1.39k
Fair Value
2.4% undervalued intrinsic discount
13
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/05 17:48
End of Day Share Price 2025/02/05 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Narayana Hrudayalaya Limited is covered by 30 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Prashant NairAmbit Capital
null nullAnand Rathi Shares and Stock Brokers Limited